ArticleCancers2021

Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results.

Ho Jung An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.